This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Refractory Reflux Esophagitis
and you are
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

To investigate the efficacy and safety of PARIET twice daily (b.i.d.) in patients with Proton Pump Inhibitor-resistant reflux esophagitis

Provided treatments

  • Drug: rabeprazole sodium

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01321567. The sponsor of the trial is Eisai Co., Ltd. and it is looking for 2157 volunteers for the current phase.
Official trial title:
Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis